A series of oxadiazole (7a-l) and hydroxypyrazoline derivatives (8a-l) incorporating thiazole were synthesized and characterized by spectral analysis 
Introduction
As per WHO, the burden of cancer will increase to 23.6 million new cases each year by 2030 [1] . Breast cancer is the most frequently diagnosed cancer and the leading cause of death in females, whereas colorectal cancer is the third most commonly diagnosed cancer in males and females [2] . The treatments for these cancers still remain a challenging task as chemotherapy is often ineffective, because of the intrinsic drug resistance to these tumours [3] . There is evidence to indicate that colorectal cancer cells are self-sufficient in growth signals, which escapes from apoptosis [4] Therefore, it is imperative to develop more effective drugs. Apoptosis is a morphologically and biochemically driven process, while impaired apoptosis and defects in the regulation of the cell cycle are hallmarks that contribute to cancer growth and aggressiveness [5] . With progressing knowledge of oncogenesis and apoptosis, comes an appreciation of the role played by cell-cycle regulation, in malignant transformation. Modulation of the cell cycle also contributes to chemotherapy resistance. The cyclin-dependent kinases1 (CDK1), cyclin-dependent kinases2 (CDK2) and DNA, the essential engines of the cell cycle, are therefore rational therapeutic targets. Over the last several years, a new class of anticancer therapy has been developed and extensively tested against these targets.
Modern studies have shown a significant fascinate in thiazole derivatives, due to farreaching biological activities, such as anticonvulsant activity [6] , anti-HIV [7] , antidiabetic [8] , anti-alzheimer [9] , antimalarial [10] , antimicrobial [11] , antiinflammatory [12] , antiproliferative against MiaPaCa-2 cell line [13] , antiproliferative against gastric carcinoma cells [14] , antiproliferative against diffuse malignant peritoneal mesothelioma cell lines, a very aggressive form of cancer [15] and CDK1 inhibitory activity of thiazol [16] . Most of the pharmaceutical drugs such as Fanetizole, Meloxicam [17] , Tiazofurin [18] and Ritonavir [19] (Fig. 1) contains thiazole rings.
On the other hand, there are a bunch of reports on 1,3,4-oxadiazoles exhibiting various pharmacological activities, such as anti-diabetic [20] , antihypertension [21] , analgesic [22] , antiviral [23] , anticonvulsant [24] , antifungal [25] antibacterial [26] , anticancer [27] , anti-glycation [28] , anti-inflammatory [29] , antimicrobial [30] , and ulcerogenic [31] . Compounds containing oxadiazole units such as Nesapidil, Furamizole, and Zibotentan [32] (Fig. 1 ) are currently used in clinical medicines. Additionally, pyrazolines incorporated with a variety of functional groups or substituents are found in many important biologically active compounds and significant research on this species has been carried out. They exhibit a wide range of biological activities such as antidepressant, anti-inflammatory, antimicrobial, and anticancer effects etc. In accordance with literature, pyrazoline derivatives are not useful in treatment of various cancer types, including lung, breast, colon, rectum, brain, stomach, liver, bladder, pancreas, bone, mouth, esophagus, cervix and prostate cancers, and also some of them act as cancer chemopreventive agents [33, 34, 35, 36, 37, 38] .
Numerous analysis shown, pyrazoline derivatives were reported as epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors [39] , COX-2/B-Raf inhibitors [40] , aurora kinase inhibitors [41] , tubulin assembling inhibitors [42] , telomerase inhibitors [43] . Provoked by above-mentioned observations and in continuation of our search for potent and less toxic antiproliferative agents, we have aspired to introduce some hybrids by combining thiazole-oxadiazole and thiazole-hydroxypyrazoline pharmacophores in a molecular framework.
Dinesh et al. [44] published anticancer activity of hydroxypyrazoline against MCF-7, MDA-MB-cancer cell lines. Samir Bondock et al. [45] reported 1,3,4-oxadiazole with antitumor activities against HepG2, WI-38, VERO, MCF-7 cancer cell lines, N.C. Desai et al. [11] analyzed 1,3,4-oxadiazole clubbed thiazole with anticancer activity against HeLa cell lines and M.F. Hassan et al. [46] disclosed DNA binding studies of 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives. Based on literature survey, the interaction of thiazole-hydroxypyrazoline derivatives in a molecular framework has so far not been studied whereas there exists a report on some of the thiazole-oxadiazole derivatives as antitubercular agent [47] but not reported as antiproliferative agents. This flurry encouraged us on synthesis, purification and characterization of thiazole-oxadiazoles and thiazole-hydroxypyrazoline class of compounds, for relatively safe alternatives to ameliorate the clinical consequences of the breast and colorectal cancers.
Results and discussion

Chemistry
The multistep reaction sequence for the synthesis of the objective compounds 7a-l and 8a-l (Table 1) are framed in Fig. 2 . 3-Cyanopyridine was taken as a starting material which on treatment with H 2 S gas in the presence of triethylamine in absolute alcohol, gave pyridine-3-carbothioamide 1, which on further reaction with ethyl-2-chloroacetoacetate yielded ethyl-4-methyl-2-(pyridin-3-yl)- 13 C-NMR spectra exhibited different types of carbons, thereby confirming the structure of 7h. The LC-MS spectrum of 7h revealed the presence of molecular ion peak at 322 (Mþ1), which was in agreement with the molecular weight of the respective compound. Scaffolds 8a-l were obtained by condensation of chalcone-dibromides 5a-l (which were obtained from chalcones 4a-l by well-known Claisen-Schmidt reaction) with 3 in presence of catalytic amount of triethylamine using ethanol as sol- confirmed the presence of pyrazoline ring in which singlet at d 29.3 and 94.6 are due to the sp [3] carbon of C-4 and C-5 respectively. Singlet at 19.0 and 165.6 are due to methyl and carbonyl carbon respectively. whereas, other aromatic carbon appeared in the expected region. Molecular ion peak at 477.61 (Mþ1), which was in agreement with the molecular weight of 8g confirmed the structure.
3. Biological activity 3.1. In vitro cytotoxicity
As per the IC 50 data (Table 2) , nine derivatives, 7d, 7e, 7f, 7i, 7l, 8a, 8b, 8i, and 8l, have shown significant inhibition on both MDA-MB231and HT 29 cancer cell Table 1 . Derivatives of 7a-l and 8a-l. 
Flow cytometry assay
To investigate the effect of compound 7i and 8i on the progression of cell cycle, incurred in the DNA content in different phases of cell cycle (G0/G1, S, and G2/M) compared to control, indicating that the compound did not induce cytotoxicity via cell cycle arrest in MDA-MB231 cells. But the compound 8i induced G0/G1 arrest in the HT-29 cells. The percentage of G0/G1 phase increased from 42.36 to 71.1 % compared to that of control cells. There was a significant reduction in the cellular DNA content of S and G2/M phases compared to that of control cells. These results indicate the antiproliferative action of 8i on the colorectal cancer cells via cell cycle arrest (Fig. 3 ).
Molecular docking studies
As per flowcytometric results CDK-2 (5iev) and BCL-2 proteins were selected for molecular docking of compounds 7i and 8i respectively. Compounds 7i (chemscore and O14 groups of the ligand. From this result, it is inferred that 7i and 8i molecules are a promising cancer inhibitor of synthetic origin (Fig. 4 ).
DNA binding studies
The Interactions of prepared compounds 7a-l and 8a-l with CT-DNA was monitored by absorption titrations using UV-visible spectrophotometer in 290e340 nm range.
In the presence of increasing amount of DNA, the spectra of 7a-l and 8a-l (except 7e, 7j and 8b, because of forming precipitation in the buffer) compounds, showed a decrease in the intensity of the band, but the bands were shifted to either lower wavelength or higher wavelength region. The change in absorbance values with increasing amounts of CT-DNA was used to calculate the binding constant of 7a-l and 8a-l. Due to the strong stacking interaction between an aromatic chromophore and the base pairs of DNA, the binding constants concluded that 7a-l and 8a-l interacted with CT-DNA through intercalation mode, which is well supported by the available literature for similar kind of compounds [48, 49, 50, 51, 52] . It is also indicated that the compound form adducts with DNA through intercalation and was stabilized by hydrophobic and hydrogen bond interactions [53, 54, 55, 56] . Hence, the compounds revealed a stronger binding affinity towards DNA double helix (Fig. 5 , Table 3 ). 
DNA docking studies
The compound 7i and 8i have been docked with a double-helical B-DNA of (Fig. 6 ). The results obtained from experiments proposed that the synthesized compound interacted with DNA groves and intercalation. The compounds 7i and 8i fits snugly within the minor groove in the A-A-T-T center. The mode of intercalation of this complex between the DNA base pairs is primarily due to effective stacking forces between the aromatic nucleus and DNA bases [57] . Molecular docking simulation was used to gain an insight of preferential docked location and orientation of the complexes within the DNA groove. It is confirmed that the proposed structure 7i and 8i should be capable of binding to DNA base sequences.
Conclusion
A series of oxadiazole derivatives 7a-l and hydroxypyrazoline derivatives 8a-l incorporating thiazole were synthesized with agreeable yield and their structures were confirmed by spectroscopic techniques. The in vitro cytotoxicity was evaluated for 7a-l and 8a-l on two human cell lines, MDA-MB231 and HT-29. Among the series, compounds 7i and 8i exhibited the most potent antiproliferative activity on both MDA-MB231 and HT-29 cell lines. It was also observed that 7i showed cell cycle arrest in Go/G1 phase on both cell lines. Whereas, 8i revealed the cell cycle arrest in Go/G1 phase on the colorectal cancer cells. Further, 7i (Chemscore 3.90) and 8i
(Chemscore 3.70) showed good interaction within the binding site of the CDK-2 protein (5iev) and BCL-2 respectively. In addition, 7a-l and 8a-l (except 7e, 7j and 8b due to the formation of precipitation in the buffer) interacted with CT-DNA via intercalation mode. Furthermore, DNA docking indicated that 7i and 8i interacted with DNA groves and intercalation. Overall, these compounds act as multi- targeting agents, as they can interact with protein target cdk (7i) and BCL-2 (8i) as well as DNA, which are the essential engines for the cell cycle. Thus, these compounds can be further studied as antiproliferative lead structures, to lay the foundation for developing anticancer drugs.
Experimental
Materials and methods
All the reagents for the present study were purchased from commercial suppliers of 
Synthesis of pyridine-3-carbothioamide (1)
Pyridine-3-carbothioamide [58] 1 was synthesized by passing H 2 S to a stirring solution (750 rpm) of 3-cyanopyridine in presence of trimethylamine (TEA) at RT for 8
hrs. The progress of the reaction was monitored by TLC. The precipitate formed in the reaction medium was filtered and recrystallized from ethanol.
Synthesis of ethyl
Mixture of Pyridine-3-carbothioamide 1 (2 g, 0.0144 mol) and ethyl-2-chloroacetoacetate (2.04 g, 0.0144 mol) was refluxed at 65 C for 8 hrs. The progress and completion of the reaction was confirmed by TLC. The reaction mixture was cooled and poured into ice cold water, the precipitate formed was filtered and recrystallized from ethanol. 
Ethyl 4-methyl
CDCl 3 , d ppm): 1.3 (t, 3H, -CH 3 , J ¼ 4.8 Hz), 2.49 (s, 3H, -CH 3 ), 4.39 (q, 2H
Procedure for the synthesis of chalcone (4a-l)
4a-l are prepared by Claisen Schmidt condensation between substituted acetophenones and substituted aldehydes in presence of NaOH as base at RT. The product formed was confirmed by TLC and poured into ice cold water, the precipitate formed was filtered and recrystallized from ethanol.
Procedure for the synthesis of chalcone dibromides (5a-l)
To a solution of chalcones 4a-l (0.01 mol) in glacial acetic acid (50 mL), bromine (0.01 mol) in glacial acetic acid (25 mL) was added slowly with vigorous stirring (700 rpm) at RT for 12 hrs. The reaction mixture was poured into ice cold water the precipitate formed was filtered and recrystallized from ethanol.
Procedure for the synthesis of hydroxypyrazolines derivatives (8a-l)
To a mixture of chalcone dibromides 5a-l (0.1 mol) in absolute ethanol (7.5 mL) 4-methyl-2-(pyridin-3-yl)-1,3-thiazole-5-carbohydrazide 3 (0.1 mol) and triethylamine (1 mL) were added and the reaction mixture was heated under reflux for 10 hrs on a water bath. The contents were cooled and poured into ice cold water.
The resulting hydroxypyrazolines derivatives 8a-l were collected by filtration and recrystallized from ethanol.
5.10. General procedure for the synthesis of (7a-l)
To a mixture of substituted aromatic and aliphatic acids 6a-l, (0.01 mol) in POCl 3 (15 mL) 5-methyl-2-(pyridin-3-yl)-1,3-thiazole-4-carbohydrazide 3 (0.01 mol) was added. The reaction mixture was heated under reflux at 90 C for 10 hrs on an oil bath. The contents were cooled, neutralized by sodium bicarbonate and poured into crushed ice. The resulting substituted thiazole-oxadiazoles 7a-l, were collected by filtration and recrystallized from ethanol. 
3-{5-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]-4-methyl-1,3-thiazol-2-yl}pyridine (7a)
Yield
4-{5-[4-methyl-2-(pyridin-3-yl)-1,3-thiazol-5-yl]-1,3,4-oxadiazol-2-yl}aniline (7d)
Yield 70%; m.p. 236e238 C; IR (cm 
(C¼N), 2941 (C-H), 3045 (Ar C-H), 3286, 3221 (-NH
3-{5-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]-4-methyl-1,3-thiazol-2-yl}pyridine (7j)
Yield 90%; m.p. 218e220 C; IR (cm 
3-(
4-methylphenyl)-5-(4-methylphenyl)-5-hydroxy-4,5- dihydro-1H-pyrazol-1-yl)[4-methyl-2-(pyridin-3-yl)-1,3-thiazol-5- yl]methanone (8c)5.10.16. 3-(2,4-dichlorophenyl)-5-(3,4-dimethoxyphenyl)-5- hydroxy-4,5-dihydro-1H-pyrazol-1-yl)[4-methyl-2-(pyridin-3-yl)- 1,3-thiazol-5-yl]methanone (8d) Yield 79%; m.p.122e124 C; IR (cm À1 ): 698 (C-S), 1224 (C-O-C),
Flow cytometry
To concentrate the impact of compounds 7i and 8i on different phase of MDA-MB231 and HT 29 cell cycle, Flow cytometric studies were carried out. Cells were seeded at a density of 0.5 million cells in 60 mm dishes. 24 hrs after seeding, they were treated with IC 50 concentration of the drug 7i and 8i, 48 hrs following drug addition, cells were harvested by trypsinization, washed with ice-cold PBS and fixed with 70% chilled ethanol. Fixed cells were stored at -20 C for 48 hrs. Cells in ethanol were centrifuged at 3000 rpm for 20 minutes, ethanol was removed and washed with PBS. Cells were incubated with 200 mL of 50 mg/mL solution of RNase A at 37 C for 5 hrs and added with 1 mL Propidium iodide. Cell cycle analysis was done using analytical flow cytometer (Guava EasyCyte, Merck Millipore).
Molecular docking studies
The crystal structures from PDB 5iev of Cyclin-dependent kinase 2 with Roniciclib (for 7i) and 4LVT from PDB of B-cell lymphoma 2 (BCL-2) with Navitoclax (for 8i) was used for the study. The protein was prepared by removing all water molecules and adding all hydrogen atoms. The ligands 7i and 8i was docked into the active sites using the molecular docking software SYBYL ver 7.3 (Tripos, L.P.) Surflex-Dock (BioPharmics LLC.) with the default parameters. The proprietary software is licensed to Manipal Institute of Technology, Manipal University, India. Surflex-Dock is a program for calculating the docking modes of small molecules into protein-binding sites. In this study, we have used ChemScore, a scoring function that is derived from regression against ligand-receptor binding free energies. In the docking process, the active site was defined. For each ligand, 20 conformations were generated (40 Â 20 ¼ 800 conformations) and then docked into M1 mAChR.
DNA binding studies
Electronic absorption spectroscopy, is one of the most common techniques for the investigation of the binding mode of small molecules to DNA [59] . All the experiments involving the binding of prepared compounds with CT-DNA, were carried out in double distilled water. A solution of CT-DNA in 50 mM NaCl/5 mM TriseHCl (pH 7.2) buffer, gave a UV absorbance at 260 and 280 nm and was found to be 1.8e1.9, indicating that the DNA was sufficiently free of protein [55] . A concentrated stock solution of DNA, was prepared in 5 mM TriseHCl/ 50 mM NaCl in water at pH 7.0 and the concentration of CT-DNA was determined per nucleotide by taking the absorption coefficient (6,600 dm 3 mol -1 cm À1 ) at 260 nm. The compounds (except 5e and 5j, because of forming precipitation in buffer) were dissolved in DMF solution for all the experiments. Absorption titration experiments, were performed with a fixed concentration of the compound (10e25 mM), and increasing concentration of DNA (0e350 mM). After equilibrium was reached (ca. 5 min), the spectra were recorded against an analogous blank solution containing the same concentration of DNA. To enable quantitative comparison of the DNA binding affinities, the intrinsic binding constant (K b ) of the complexes for binding with CT-DNA were obtained by the following equation [46] . 
DNA docking
The crystal structure 6BNA [56] from PDB with netropsin was used for the study.
The DNA structure was prepared by removing the bound netropsin molecule and removing all water molecules to avoid potential interference with the docking.
The binding site was defined using an atom in the center of the DNA molecule and was large enough, that it encompassed netropsin binding site.
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